Our Firm

Our Firm

Green Griffith is a preeminent intellectual property law firm, uniquely qualified to assist small and mid-sized pharmaceutical and biotech companies protect their most valuable assets and position them for future success.
Learn More >
Our Team

Our Team

Our technical knowledge makes the difference: all of our attorneys have degrees in pharma-related fields, including organic chemistry, chemical engineering and molecular biology, and many have advanced degrees.
Learn More >
Our Clients

Our Clients

Our clients are both generics and brand, small and mid-sized pharmaceutical and biotech companies, focused on securing market position and/or overcoming obstacles to new product entry for their drugs and therapies.​​
Learn More >

News and Insights

Aug 16, 2018

USPTO Issues Updates to PTAB Trial Practice Guide

USPTO has released an update to the PTAB Trial Practice Guide (“TPG”). A copy of this August 2018 update, which contains only the r…
Read More >
Aug 15, 2018

Bob Green Named One of
The Best Lawyers in America 2019

Green Griffith is pleased to announce that founding partner Bob Green has been selected by his peers for inclusion in The Best Lawyers in America…
Read More >
Aug 14, 2018

Federal Circuit Rejects USPTO’s Effort to Circumvent the “American Rule” Regarding Recovery of Attorneys’ Fees in § 145 Appeals

A divided Federal Circuit has determined that 35 U.S.C. § 145, which permits the USPTO to recover “all the expenses of the proceeding…
Read More >
Aug 7, 2018

Federal Circuit Broadens Test for Identifying the “Real Party in Interest” in Inter Partes Reviews

A determination of the “real party in interest” or “privy” of an IPR petitioner is significant for at least two reaso…
Read More >